Synthesis and anti-CVB3 activity of 4-amino acid derivative substituted pyrimidine nucleoside analogues. 2020

Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
High & New Technology Research Center of Henan Academy of Sciences, Zhengzhou, Henan Province 450002, PR China.

Seven novel 4-amino acid derivative substituted pyrimidine nucleoside analogues were designed, synthesized, and tested for their anti-CVB3 activity. Initial biological studies indicated that among these 4-amino acid derivative substituted pyrimidine nucleoside analogues, 4-N-(2'-amino-glutaric acid-1'-methylester)-1-(2'- deoxy-2'-β-fluoro-4'-azido)-furanosyl-cytosine 2 exhibited the most potent anti-CVB activity (IC50 = 9.3 μM). The cytotoxicity of these compounds has also been assessed. The toxicity of compound 2 was similar to that of ribavirin.

UI MeSH Term Description Entries
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
January 2009, Zeitschrift fur Naturforschung. C, Journal of biosciences,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
February 2022, Organic & biomolecular chemistry,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
February 2014, Bioorganic & medicinal chemistry letters,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
September 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
August 2003, The Journal of organic chemistry,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
June 2016, ChemistryOpen,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
February 1994, Journal of medicinal chemistry,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
December 2022, Organic & biomolecular chemistry,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
March 2010, Nucleosides, nucleotides & nucleic acids,
Le Tao, and Yujiang Li, and Xiaohe Guo, and Lihong Dong, and Luping Liu, and Qiang Wang, and Xuejun Yu, and Chuanjun Song, and Junbiao Chang
November 2006, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!